Rakuten Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
$955K Buy
+3,559
New +$955K ﹤0.01% 501
2024
Q3
$636K Buy
2,314
+575
+33% +$158K ﹤0.01% 411
2024
Q2
$430K Buy
1,739
+653
+60% +$161K ﹤0.01% 413
2024
Q1
$162K Buy
1,086
+996
+1,107% +$149K ﹤0.01% 447
2023
Q4
$17.6K Buy
+90
New +$17.6K ﹤0.01% 433